Whereas studies revealed an upregulation of ACTBL2 in pancreatic, colorectal and hepatocellular carcinoma, investigations focusing on its carcinogenetic impact in gynecological malignancies are still missing (16, 18, 19). The gene discussed is ACTBL2; the disease is hepatocellular carcinoma.